Latest Amorfix Life Sciences Ltd. Stories
TSX: AMF TORONTO, Jan. 22, 2014 /CNW/ - Amorfix Life Sciences Ltd.
WATERTOWN, Mass., Dec. 8 /PRNewswire/ -- EnVivo Pharmaceuticals today reported the successful reduction in the levels of aggregated Abeta or Beta-Amyloid in an aged transgenic model (Tg2576) of Alzheimer's disease with its lead gamma-secretase modulator (GSM) EVP-0962.
- The parings of haberdine; also, any kind of fragments.